Using FACS, we validated this prediction in two human DLBCL models (SU-DHL4 IRF8 KO, Toledo IRF8 WT, and mutants) with detectable CLIP levels on the cell surface (fig. This evidence concerns the gene IRF8 and diffuse large B-cell lymphoma.